Two Sigma Investments 13F: Cuts Aflac (AFL) Stake by $18M

Two Sigma Trims Back Aflac Position

Two Sigma Investments scaled back its position in Aflac Incorporated (NYSE: AFL) during the most recent reporting period. According to the quantitative investment firm's latest Form 13F filing with the SEC, the fund trimmed its holdings by 23.7%. This reduction involved selling 148,448 shares of the life insurance provider.

Following the transaction, Two Sigma Investments retained 478,735 shares of the company. The remaining holding was valued at $57,520,011 at the close of the reporting period. Because 13F filings are backward-looking documents that reflect holdings at the end of a specific quarter, this data may not represent the fund's current, real-time portfolio allocations.

Aflac Stock Navigates Stable Range

On Sunday, the stock traded around $120.15, hovering near its 50-day moving average of $120.60. Aflac has shown steady price action, remaining above its 200-day moving average of $114.85. Over the past year, the stock has traded between a low of $105.43 and a high of $130.22.

With a price-to-earnings (P/E) ratio of 12.42 and a forward P/E of 15.27, investors are paying a reasonable premium for Aflac's earnings stream. The company's beta of 0.58 highlights its defensive nature, indicating the stock is significantly less volatile than the broader market.

Dividend and Earnings Outlook

Aflac continues to share its profits with investors. The company pays an annual dividend of $2.44 per share, which translates to a dividend yield of 2.1%. With a payout ratio of 25.7%, Aflac keeps plenty of earnings on hand to fund its operations and future expansion while maintaining a secure dividend payment.

Financially, the company remains highly profitable despite flat top-line growth. Aflac pulled in revenue of $18.07 billion, though its revenue growth dipped slightly by 0.01%. Still, the insurer maintained a strong net margin of 26.9% and generated a return on equity (ROE) of 16.9%. Shareholders can mark their calendars for November 4, 2026, when Aflac is scheduled to report its next batch of quarterly earnings.

Japan Post and Insiders Adjust Holdings

Insider activity has been busy at Aflac, characterized by major planned divestments by institutional partners and mixed personal transactions. Japan Post Holdings Co., Ltd., which holds a 10% owner status, executed several planned sales. On October 14, 2026, Japan Post sold 55,000 shares at an average price of $117.79, totaling $6,478,472. Just a day earlier, on October 13, 2026, the firm sold 42,000 shares at $116.38 for a total value of $4,887,763. This followed smaller planned sales in June, where Japan Post divested 3,300 shares on June 18 at $116.92 and 26,300 shares on June 17 at $116.62.

Meanwhile, insider Joseph Moskowitz had a busy day on June 22, 2026. Moskowitz bought 20,303 shares at a bargain average price of $44.59, representing an investment of $905,311. On that very same day, Moskowitz sold 12,370 shares at $116.54, taking home $1,441,600. These insider moves show diverse motivations, from personal portfolio rebalancing to long-term corporate divestment programs.

Wall Street Refines Price Targets

Several research firms have updated their outlooks on Aflac. On October 15, 2026, JP Morgan maintained a Neutral rating on the stock while raising its price target to $119.00 from $116.00. On October 12, 2026, Wells Fargo kept an Equal-Weight rating but adjusted its price target down to $116.00 from $122.00. Keefe, Bruyette & Woods also lowered its expectations on October 9, 2026, keeping a Market Perform rating but shaving its target to $120.00 from $125.00.

More bearish views came from Mizuho, which maintained an Underperform rating on October 7, 2026, with a target of $107.00, and Barclays, which kept an Underweight rating on the same day with a target of $101.00. Overall, across 15 analyst opinions, the stock has a consensus mean price target of $118.53, ranging from a cautious low of $99.00 to an optimistic high of $138.00.

Supplemental Insurance Giant

Aflac Incorporated provides supplemental health and life insurance products, operating through dedicated Japan and U.S. business segments. The company is famous for helping policyholders pay out-of-pocket medical bills that major medical plans do not cover. Two Sigma's decision to trim its holdings represents a portfolio adjustment rather than a major shift in the insurer's underlying business model, which remains supported by reliable underwriting income.

What to Watch at Aflac Incorporated

Market observers should keep an eye on upcoming regulatory filings to see if other quantitative funds follow Two Sigma's lead. The key upcoming catalyst will be Aflac's quarterly earnings release on November 4, 2026. This report will provide the next clear look at how claims trends and investment yields are shaping the insurer's bottom line.